AKUMS vs RELIANCE
Head-to-head DCF comparison · AKUMS DRUGS AND PHARMA L vs Reliance Industries
Model Favors
AKUMS shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
AKUMS
AKUMS DRUGS AND PHARMA L
General/Diversified
₹514
Above Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,356
Data Limited| Metric | AKUMS | RELIANCE |
|---|---|---|
| Verdict | Above Fair Value | Data Limited |
| YieldIQ Score | 52/100 | 45/100 |
| Fair Value | ₹333 | ₹545 |
| Current Price | ₹514 | ₹1,356 |
| Margin of Safety | -35.2% | -59.8% |
| Moat | Narrow | Wide |
| Piotroski F-Score | 7/9 | 6/9 |
| ROE | — | 8.3% |
| Debt / Equity | 0.03 | — |
| EV / EBITDA | 13.3× | 18.2× |
| Market Cap | ₹7,874 Cr | ₹18.35 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.